Anti-HER2 CAR-T Cell Injection

· UTC Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-HER2 CAR-T Cell Injection, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors [NA]